54.174.225.82
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

FDA Alerts

FDA approves cream for plaque psoriasis

The U.S. Food and Drug Administration has approved calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064% (Wynzora cream; MC2 Therapeutics) for once-daily topical treatment of plaque psoriasis in adults 18 years of age or older. Approval is based on a phase 3 clinical trial of 794 patients which showed at least a 2-grade...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-